USSTOCK.TODAY
Pre-Market
Log in Sign up

Cardinal Health and Edwards Lifesciences shares rise on strong earnings

Nasdaq +1 · ·by G4L

EW Edwards Lifesciences Corp
$105.80 -0.01%
View chart & analysis →
  1. 1Cardinal Health recorded a 5% revenue growth rate for the first quarter of 2027.
  2. 2The full-year 2027 adjusted EPS guidance for Cardinal Health was raised to $12.8-$13.
  3. 3Edwards Lifesciences reported third-quarter revenue of $1.72 billion, up 10.5%.

So what's the key point?

Cardinal Health and Edwards Lifesciences saw improved performance due to high sales. Stock prices rose as experts increased the profit outlook for Cardinal Health.

Source Nasdaq +1 · View original ↗

Related 3-line summaries

Edwards Lifesciences beats earnings and revenue estimates, improving performance for three consecutive quarters Nasdaq +1 · Nov 5Nike Downgraded; Home Depot Coverage Initiated The Fly · Oct 6Banner Corporation to release Q2 earnings on July 23 GuruFocus.com +4 · Jul 24
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news